212 filings
Page 7 of 11
8-K
01e jv4tfm80
2 May 19
Seres Therapeutics Reports First Quarter Financial Results and Provides Clinical Pipeline Progress Update
7:03am
DEFA14A
y0smfo 673ag
30 Apr 19
Additional proxy soliciting materials
4:14pm
8-K
fb8bmu3o8 4n2zi8yo
18 Apr 19
Departure of Directors or Certain Officers
4:05pm
CT ORDER
91ghqvu9l
15 Apr 19
Confidential treatment order
3:42pm
8-K
ve1cl8 6d
11 Mar 19
Entry into a Material Definitive Agreement
10:02am
S-8
pch8 yylefs3k
6 Mar 19
Registration of securities for employees
1:11pm
8-K
n9yeg
6 Mar 19
Results of Operations and Financial Condition
7:00am
8-K
p5grdcfldiaop6b55q5h
15 Jan 19
Departure of Directors or Certain Officers
7:10am
8-K
bj9 48uo7o
21 Nov 18
Departure of Directors or Certain Officers
8:50am
8-K
movxgjugkm5ry
8 Nov 18
Seres Therapeutics Reports Third Quarter Financial Results and Provides Operational Updates
7:05am
8-K
n0gob1mi
7 Nov 18
Entry into a Material Definitive Agreement
4:13pm
8-K
7oc e55lpdm8tgbwkup
22 Oct 18
Departure of Directors or Certain Officers
7:03am
8-K
rraf16 kljes
4 Sep 18
Departure of Directors or Certain Officers
12:00am
8-K
dzvudq55hvixik
7 Aug 18
Regulation FD Disclosure
1:06pm
8-K
qe2bg8v1
2 Aug 18
Seres Therapeutics Reports Second Quarter Financial Results and Provides Operational Updates
7:08am
8-K
9b0pkd3n wo4p
27 Jun 18
Submission of Matters to a Vote of Security Holders
4:35pm